PTC299 for Treatment of Advanced Cancer
Is a
Allocation Type
Non-Randomized
0
Intervention Model
Parallel Assignment
0
Intervention Name
PTC299
0
Docetaxel
0
Interventional Trial Phase
Phase 1
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Drug
0
Last Updated
May 10, 2019
0
Masking Type
None (Open Label)
0
Primary Completion Date
February 24, 2012
0
Trial Recruitment Size
76
0
Trial Sponsor
Clinical Trial Start Date
July 3, 2008
0
Study Completion Date
February 24, 2012
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase 1b Study to Assess the Safety Profile, Pharmacokinetics, and Anti-VEGF Activity of PTC299 in Patients With Advanced Cancer
0
Official Website
Find more entities like PTC299 for Treatment of Advanced Cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.